HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Shuanghu Yuan Selected Research
Shuanghu Yuan Research Topics
Disease
32
Neoplasms (Cancer)
10/2022 - 10/2010
21
Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
04/2022 - 06/2007
10
Lung Neoplasms (Lung Cancer)
01/2022 - 10/2010
8
Brain Neoplasms (Brain Tumor)
01/2022 - 10/2014
7
Small Cell Lung Carcinoma (Small Cell Lung Cancer)
05/2022 - 10/2014
5
Neoplasm Metastasis (Metastasis)
01/2022 - 03/2009
4
Esophageal Squamous Cell Carcinoma
10/2020 - 10/2017
4
Esophageal Neoplasms (Esophageal Cancer)
01/2020 - 01/2014
3
Lymphatic Metastasis
01/2017 - 08/2006
2
Adenocarcinoma of Lung
01/2022 - 11/2018
2
Carcinoma (Carcinomatosis)
01/2020 - 01/2014
2
Glioblastoma (Glioblastoma Multiforme)
11/2017 - 04/2016
2
Hypoxia (Hypoxemia)
01/2016 - 10/2010
2
Squamous Cell Neoplasms (Squamous Cell Cancer)
05/2009 - 08/2006
1
Uterine Cervical Neoplasms (Cancer of the Cervix)
10/2022
1
Edema (Dropsy)
01/2018
1
Necrosis
01/2018
1
Glioma (Gliomas)
11/2017
1
Hepatocellular Carcinoma (Hepatoma)
11/2016
1
Lewis Lung Carcinoma
01/2015
1
Circulating Neoplastic Cells
10/2014
1
Deglutition Disorders (Dysphagia)
08/2014
1
Hemorrhage
08/2014
1
Melanoma (Melanoma, Malignant)
01/2014
1
Rare Diseases (Rare Disease)
01/2014
1
Chronic Obstructive Pulmonary Disease (COPD)
03/2013
1
Pulmonary Hypertension
04/2009
1
Congenital Heart Defects (Congenital Heart Defect)
04/2009
Drug/Important Bio-Agent (IBA)
6
Integrins
IBA
01/2022 - 12/2014
6
alfatide II
IBA
01/2022 - 01/2015
6
Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)
FDA Link
08/2018 - 08/2006
3
Biomarkers (Surrogate Marker)
IBA
03/2022 - 01/2020
3
1,4,7- triazacyclononane- N,N',N''- triacetic acid (NOTA)
IBA
01/2022 - 01/2019
3
Peptides (Polypeptides)
IBA
01/2022 - 12/2014
2
Radioisotopes (Radionuclides)
IBA
01/2022 - 12/2014
2
Tyrosine Kinase Inhibitors
IBA
01/2022 - 01/2011
2
Glucose (Dextrose)
FDA Link
Generic
01/2019 - 09/2017
2
aspartic acid glycine arginine
IBA
01/2019 - 12/2015
2
fluoromisonidazole
IBA
12/2018 - 01/2016
2
Fluorine-18
IBA
11/2017 - 09/2017
2
MicroRNAs (MicroRNA)
IBA
04/2017 - 11/2016
2
S100 Proteins (S 100 Protein)
IBA
01/2014 - 01/2014
2
Biological Products
IBA
10/2012 - 10/2010
1
pegylated granulocyte colony-stimulating factor
IBA
05/2022
1
Granulocyte Colony-Stimulating Factor (G-CSF)
IBA
05/2022
1
Docetaxel (Taxotere)
FDA Link
04/2022
1
Immune Checkpoint Inhibitors
IBA
04/2022
1
sintilimab
IBA
04/2022
1
Proteins (Proteins, Gene)
FDA Link
01/2022
1
68Ga-FAPI
IBA
01/2022
1
B7-H1 Antigen
IBA
10/2021
1
Circulating Tumor DNA
IBA
01/2020
1
apatinib
IBA
04/2019
1
Acids
IBA
01/2019
1
Fluorides
IBA
01/2019
1
Aluminum
IBA
01/2019
1
triazacyclononane
IBA
01/2019
1
3-azido-2,7-naphthalene disulfonate
IBA
12/2018
1
Inosine Triphosphate (ITP)
IBA
08/2018
1
Endostatins
IBA
11/2017
1
Hemoglobins (Hemoglobin)
IBA
10/2017
1
Amino Acids
FDA Link
09/2017
1
Amino Acid Transport Systems (Amino Acid Transporter)
IBA
09/2017
1
Molecular Probes (Molecular Probe)
IBA
12/2014
1
arginyl-glycyl-aspartic acid
IBA
12/2014
1
Platinum
IBA
10/2014
1
Iodine
IBA
08/2014
1
Vimentin
IBA
01/2014
1
Reticulin (Reticular Fiber)
IBA
01/2014
1
phosphatidyl-N-monomethylaminoethanol
IBA
01/2014
1
Glial Fibrillary Acidic Protein
IBA
01/2014
1
ErbB Receptors (EGF Receptor)
IBA
01/2011
1
Messenger RNA (mRNA)
IBA
01/2011
1
Enzymes
IBA
01/2011
1
Cisplatin (Platino)
FDA Link
Generic
01/2011
1
Blood Group Antigens (Blood Groups)
IBA
01/2011
1
Antigens
IBA
01/2011
1
Gemcitabine
FDA Link
01/2011
1
Erlotinib Hydrochloride (CP 358,774)
FDA Link
01/2011
1
ABO Blood-Group System
IBA
01/2011
1
Hypoxia-Inducible Factor 1
IBA
10/2010
1
Oxygen (Dioxygen)
IBA
10/2010
1
rho-Associated Kinases
IBA
04/2009
1
fasudil (AT 877)
IBA
04/2009
1
Indicators and Reagents (Reagents)
IBA
03/2009
Therapy/Procedure
23
Radiotherapy
01/2022 - 01/2011
11
Chemoradiotherapy
05/2022 - 01/2011
9
Therapeutics
03/2022 - 07/2008
9
Drug Therapy (Chemotherapy)
03/2022 - 06/2007
4
Cranial Irradiation
01/2019 - 10/2014
1
Hysterectomy
10/2022
1
Neoadjuvant Therapy
10/2022
1
Aftercare (After-Treatment)
01/2020
1
Precision Medicine
01/2020
1
Intensity-Modulated Radiotherapy (Radiotherapy, Intensity Modulated)
03/2019
1
Stents
08/2014
1
Brachytherapy
08/2014
1
Esophagectomy
01/2014
1
Conformal Radiotherapy
06/2013
1
Contraindications
03/2013